The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
分析师意见：health catalyst在5位专家眼中的表现
The...Across the recent three months, 5 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，5位分析师分享了他们对Health Catalyst（纳斯达克股票代码：HCAT）的见解，表达了从看涨到看跌的各种观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.2, along with a high estimate of $16.00 and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.08%.
分析师提供了更深入的见解，确定了12个月的目标股价，平均目标价为11.2美元，最高估计为16.00美元，低估值为7.00美元。随着分析师将平均目标股价下调了5.08％，情绪的负面转变显而易见。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
The...
对...
登录免费看全文
登录/注册
资讯热榜
更新时间